questionsmedicales.fr
Technologie, industrie et agriculture
Produits manufacturés
Matériaux biomédicaux et dentaires
Adhésifs tissulaires
Cyanoacrylates
Enbucrilate
2-Cyano-acrylate d'isobutyle
2-Cyano-acrylate d'isobutyle : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
2
Adhésifs
Chirurgie
Plaies
Allergies
Antécédents médicaux
Chirurgie
Symptômes
2
Réaction cutanée
Symptômes
Dermatologie
Douleur
Chirurgie
Effets indésirables
Prévention
2
Allergies
Prévention
Chirurgie
Précautions
Chirurgie
Stérilité
Traitements
2
Infections
Chirurgie
Plaies
Cicatrisation
Adhésifs
Chirurgie
Complications
2
Complications
Infections
Cicatrices
Réactions systémiques
Allergies
Chirurgie
Facteurs de risque
2
Facteurs de risque
Allergies
Chirurgie
Enfants
Chirurgie
Adhésifs
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "2-Cyano-acrylate d'isobutyle : Questions médicales les plus fréquentes",
"headline": "2-Cyano-acrylate d'isobutyle : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les 2-Cyano-acrylate d'isobutyle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-15",
"dateModified": "2025-04-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "2-Cyano-acrylate d'isobutyle"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Enbucrilate",
"url": "https://questionsmedicales.fr/mesh/D004659",
"about": {
"@type": "MedicalCondition",
"name": "Enbucrilate",
"code": {
"@type": "MedicalCode",
"code": "D004659",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "J01.637.051.919.367.341"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "2-Cyano-acrylate d'isobutyle",
"alternateName": "Bucrylate",
"code": {
"@type": "MedicalCode",
"code": "D002015",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Michael Schultheiß",
"url": "https://questionsmedicales.fr/author/Michael%20Schulthei%C3%9F",
"affiliation": {
"@type": "Organization",
"name": "Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany."
}
},
{
"@type": "Person",
"name": "Max Giesler",
"url": "https://questionsmedicales.fr/author/Max%20Giesler",
"affiliation": {
"@type": "Organization",
"name": "Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany."
}
},
{
"@type": "Person",
"name": "Lars Maruschke",
"url": "https://questionsmedicales.fr/author/Lars%20Maruschke",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany."
}
},
{
"@type": "Person",
"name": "Arthur Schmidt",
"url": "https://questionsmedicales.fr/author/Arthur%20Schmidt",
"affiliation": {
"@type": "Organization",
"name": "Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany."
}
},
{
"@type": "Person",
"name": "Lukas Sturm",
"url": "https://questionsmedicales.fr/author/Lukas%20Sturm",
"affiliation": {
"@type": "Organization",
"name": "Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Cost-benefit analysis of a distracted pedestrian intervention.",
"datePublished": "2022-11-17",
"url": "https://questionsmedicales.fr/article/36396441",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/ip-2022-044740"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cost-Benefit Analysis of Tafenoquine for Radical Cure of",
"datePublished": "2022-07-11",
"url": "https://questionsmedicales.fr/article/35818703",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3346/jkms.2022.37.e212"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cost-utility and cost-benefit analysis of pediatric PCV programs in Egypt.",
"datePublished": "2022-09-07",
"url": "https://questionsmedicales.fr/article/36070504",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/21645515.2022.2114252"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cost-Benefit Analysis versus Cost-Effectiveness Analysis from a Societal Perspective in Healthcare.",
"datePublished": "2023-03-06",
"url": "https://questionsmedicales.fr/article/36901658",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph20054637"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cashing in: cost-benefit analysis framework for digital hospitals.",
"datePublished": "2024-05-31",
"url": "https://questionsmedicales.fr/article/38822341",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12913-024-11132-7"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Technologie, industrie et agriculture",
"item": "https://questionsmedicales.fr/mesh/D013676"
},
{
"@type": "ListItem",
"position": 3,
"name": "Produits manufacturés",
"item": "https://questionsmedicales.fr/mesh/D008420"
},
{
"@type": "ListItem",
"position": 4,
"name": "Matériaux biomédicaux et dentaires",
"item": "https://questionsmedicales.fr/mesh/D001697"
},
{
"@type": "ListItem",
"position": 5,
"name": "Adhésifs tissulaires",
"item": "https://questionsmedicales.fr/mesh/D014014"
},
{
"@type": "ListItem",
"position": 6,
"name": "Cyanoacrylates",
"item": "https://questionsmedicales.fr/mesh/D003487"
},
{
"@type": "ListItem",
"position": 7,
"name": "Enbucrilate",
"item": "https://questionsmedicales.fr/mesh/D004659"
},
{
"@type": "ListItem",
"position": 8,
"name": "2-Cyano-acrylate d'isobutyle",
"item": "https://questionsmedicales.fr/mesh/D002015"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : 2-Cyano-acrylate d'isobutyle - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur 2-Cyano-acrylate d'isobutyle",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur 2-Cyano-acrylate d'isobutyle",
"description": "Comment le Bucrylate est-il utilisé en diagnostic ?\nQuels tests sont nécessaires avant d'utiliser le Bucrylate ?",
"url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Cost-Benefit+Analysis#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur 2-Cyano-acrylate d'isobutyle",
"description": "Quels symptômes peuvent survenir après l'application de Bucrylate ?\nLe Bucrylate peut-il provoquer des douleurs ?",
"url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Cost-Benefit+Analysis#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur 2-Cyano-acrylate d'isobutyle",
"description": "Comment prévenir les réactions allergiques au Bucrylate ?\nQuelles précautions doivent être prises lors de l'utilisation du Bucrylate ?",
"url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Cost-Benefit+Analysis#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur 2-Cyano-acrylate d'isobutyle",
"description": "Le Bucrylate est-il utilisé pour traiter des infections ?\nComment le Bucrylate favorise-t-il la cicatrisation ?",
"url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Cost-Benefit+Analysis#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur 2-Cyano-acrylate d'isobutyle",
"description": "Quelles complications peuvent survenir avec le Bucrylate ?\nLe Bucrylate peut-il causer des réactions systémiques ?",
"url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Cost-Benefit+Analysis#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur 2-Cyano-acrylate d'isobutyle",
"description": "Qui est à risque d'allergie au Bucrylate ?\nLes enfants peuvent-ils utiliser le Bucrylate ?",
"url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Cost-Benefit+Analysis#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment le Bucrylate est-il utilisé en diagnostic ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'est pas utilisé pour le diagnostic, mais pour la fermeture des plaies."
}
},
{
"@type": "Question",
"name": "Quels tests sont nécessaires avant d'utiliser le Bucrylate ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Aucun test spécifique n'est requis, mais l'historique allergique doit être vérifié."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent survenir après l'application de Bucrylate ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des rougeurs, démangeaisons ou gonflements peuvent apparaître au site d'application."
}
},
{
"@type": "Question",
"name": "Le Bucrylate peut-il provoquer des douleurs ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs légères peuvent survenir, mais elles sont généralement temporaires."
}
},
{
"@type": "Question",
"name": "Comment prévenir les réactions allergiques au Bucrylate ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évaluer l'historique allergique et effectuer un test cutané si nécessaire."
}
},
{
"@type": "Question",
"name": "Quelles précautions doivent être prises lors de l'utilisation du Bucrylate ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le contact avec les yeux et les muqueuses, et utiliser dans un environnement stérile."
}
},
{
"@type": "Question",
"name": "Le Bucrylate est-il utilisé pour traiter des infections ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, il est utilisé pour la fermeture des plaies, pas pour traiter les infections."
}
},
{
"@type": "Question",
"name": "Comment le Bucrylate favorise-t-il la cicatrisation ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il forme une barrière protectrice qui aide à maintenir l'humidité et à réduire l'infection."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec le Bucrylate ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des infections, des réactions allergiques ou des cicatrices anormales peuvent survenir."
}
},
{
"@type": "Question",
"name": "Le Bucrylate peut-il causer des réactions systémiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des réactions systémiques sont rares, mais possibles en cas d'allergie sévère."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'allergie au Bucrylate ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes ayant des antécédents d'allergies aux adhésifs ou aux cyanoacrylates."
}
},
{
"@type": "Question",
"name": "Les enfants peuvent-ils utiliser le Bucrylate ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, mais avec prudence et sous supervision médicale en raison de leur peau sensible."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 09/04/2025
Contenu vérifié selon les dernières recommandations médicales
1 publication dans cette catégorie
Affiliations :
Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
Publications dans "2-Cyano-acrylate d'isobutyle" :
1 publication dans cette catégorie
Affiliations :
Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
Publications dans "2-Cyano-acrylate d'isobutyle" :
1 publication dans cette catégorie
Affiliations :
Department of Radiology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
Publications dans "2-Cyano-acrylate d'isobutyle" :
1 publication dans cette catégorie
Affiliations :
Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
Publications dans "2-Cyano-acrylate d'isobutyle" :
1 publication dans cette catégorie
Affiliations :
Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
Publications dans "2-Cyano-acrylate d'isobutyle" :
1 publication dans cette catégorie
Affiliations :
Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
Publications dans "2-Cyano-acrylate d'isobutyle" :
1 publication dans cette catégorie
Affiliations :
Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany. Martin-Roessle@t-online.de.
Publications dans "2-Cyano-acrylate d'isobutyle" :
1 publication dans cette catégorie
Affiliations :
Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
Publications dans "2-Cyano-acrylate d'isobutyle" :
Cellphone ubiquity has increased distracted pedestrian behaviour and contributed to growing pedestrian injury rates. A major barrier to large-scale implementation of prevention programmes is unavailab...
Three data sources were used as follows: (1) fatal, severe, non-severe pedestrian injury rates from Alabama's electronic crash reporting system; (2) expected costs per fatal, severe, non-severe pedest...
Over 2019-2021, Alabama recorded an annual average of 31 fatal, 83 severe and 115 non-severe pedestrian injuries in intersections. Expected costs/injury were US$11 million, US$339 535 and US$93 877, r...
Even under the most parsimonious scenario (25% distracted pedestrians; densest beacon placement), StreetBit yields US$11.8 million estimated net annual benefit to society. Existing data sources can be...
We expanded the previously developed...
Under 0.04 primaquine relapse probability, the introduction of tafenoquine with relapse probability of 0.01 prevented 129 (12.27%) and 35 (77.78%) total and relapse cases, respectively, over the next ...
Tafenoquine could reduce...
New vaccine introductions (NVIs) raise issues of value for money (VfM) for self-financing middle-income countries like Egypt. We evaluate a pediatric pneumococcal conjugate vaccine (PCV) NVI in Egypt ...
Cost-effectiveness analysis (CEA) is the main way that economic evaluations are carried out in the health care field. However, CEA has limited validity in deciding whether any health care evaluation i...
For many countries, especially those outside the USA without incentive payments, implementing and maintaining electronic medical records (EMR) is expensive and can be controversial given the large amo...
This paper outlines the development of an evidence-based digital health cost-benefit analysis (eHealth-CBA) framework to calculate the total economic value of the EMR implementation over time. A net p...
We developed a three-stage process that takes into account the complexity of the healthcare system and its stakeholders, the investment appraisal and evaluation practice, and the existing knowledge of...
The proposed framework is the first step toward developing a comprehensive evaluation framework for EMRs to inform health decision-makers about the economic value of digital investments rather than ju...
Broad benefits of vaccination programs are well acknowledged but difficult to measure, especially when considering all vaccines included in a National Immunization Program (NIP). The aim was to conduc...
When a viral outbreak occurs, governments are obligated to protect their citizens from the diverse adverse effects of the disease. Health policymakers often have several interventions to consider base...
Despite increasing global attention to the national human papillomavirus (HPV) immunization program, this program is controversial in Iran. Evidence indicates that HPV vaccination is not cost-effectiv...
Laboratories and their criminal justice systems are confronted with challenges for implementing new technologies, practices, and policies even when there appears to be demonstrative benefits to operat...
The multiple hypothesis testing problem is inherent in large-scale quantitative "omic" experiments such as mass spectrometry-based proteomics. Yet, tools for comparing the costs and benefits of differ...